Biomedical Engineering Reference
In-Depth Information
nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Elec-
trophoresis 28:2252-2261
21. Gref R, L¨ck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, M¨ ller RH
(2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):
influences of the corona (PEG chain length and surface density) and of the core composition on
phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18:301-313
22. Price ME, Cornelius RM, Brash JL (2001) Protein adsorption to polyethylene glycol modified
liposomes from fibrinogen solution and from plasma. Biochim Biophys Acta Biomembr
1512:191-205
23. Arima Y, Kawagoe M, Toda M, Iwata H (2009) Complement activation by polymers carrying
hydroxyl groups. ACS Appl Mater Interfaces 1:2400-2407
24. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A (2011) Assessing the in vitro
and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 112:2323-2338
25. Mager MD, LaPointe V, Stevens MM (2011) Exploring and exploiting chemistry at the cell
surface. Nat Chem 3:582-589
26. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011)
Protein
nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610-5637
27. Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA (2012) Designing the
nanoparticle-biomolecule interface for “targeting and therapeutic delivery”. J Control Release
161:164-174
28. Caracciolo G, Pozzi D, Capriotti A, Cavaliere C, Cardarelli F, Bifone A, Lagan` A (2012)
Cancer cell targeting of lipid gene vectors by protein corona. In: NSTI (ed) Nanotechnology
2012: bio sensors, instruments, medical, environment and energy, vol 3. CRC, Boca Raton, pp
354-357
29. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to
cells and tissue. Adv Drug Deliv Rev 55:329-347
30. Carver LA, Schnitzer JE (2003) Caveolae: mining little caves for new cancer targets. Nat Rev
Cancer 3:571-581
31. Gould GW, Lippincott-Schwartz J (2009) New roles for endosomes: from vesicular carriers to
multi-purpose platforms. Nat Rev Mol Cell Biol 10:287-292
32. Mukhopadhyay D, Riezman H (2007) Proteasome-independent functions of ubiquitin in
endocytosis and signaling. Science 315:201-205
33. Goppert TM, Muller RH (2005) Polysorbate-stabilized solid lipid nanoparticles as colloidal
carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorp-
tion patterns. J Drug Target 13:179-187
34. Goppert TM, Muller RH (2005) Protein adsorption patterns on poloxamer- and poloxamine-
stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm 60:361-372
35. Foote M (2007) Using nanotechnology to improve the characteristics of antineoplastic drugs:
improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel. Biotechnol
Annu Rev 13:345-357
36. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW
(2005) Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol
146:882-893
37. Dobrovolskaia MA, McNeil SE (2007)
Immunological properties of
engineered
nanomaterials. Nat Nanotechnol 2:469-478
38. Keogh JR, Velander FF, Eaton JW (1992) Albumin-binding surfaces for implantable devices.
J Biomed Mater Res 26:441-456
39. Podolski IY, Podlubnaya ZA, Kosenko EA, Mugantseva EA, Makarova EG, Marsagishvili
LG, Shpagina MD, Kaminsky YG, Andrievsky GV, Klochkov VK (2007) Effects of hydrated
forms of C
60
fullerene on amyloid
-peptide fibrillization
in vitro
and performance of the
cognitive task. J Nanosci Nanotechnol 7:1479-1485
40. Ghavami M, Rezaei M, Ejtehadi R, Lotfi M, Shokrgozar MA, Abd Emamy B, Raush J,
Mahmoudi M (2013) Physiological temperature has a crucial role in amyloid beta in the
β
